These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 10418031)
21. Laboratory diagnosis of antibiotic-associated diarrhea: a Polish pilot study into the clinical relevance of Clostridium difficile and Clostridium perfringens toxins. Pituch H; Obuch-Woszczatyński P; Wultańska D; van Belkum A; Meisel-Mikołajczyk F; Łuczak M Diagn Microbiol Infect Dis; 2007 May; 58(1):71-5. PubMed ID: 17300901 [TBL] [Abstract][Full Text] [Related]
22. Susceptibility testing of Clostridium difficile against metronidazole and vancomycin by disk diffusion and Etest. Wong SS; Woo PC; Luk WK; Yuen KY Diagn Microbiol Infect Dis; 1999 May; 34(1):1-6. PubMed ID: 10342100 [TBL] [Abstract][Full Text] [Related]
23. Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates. Schaumann R; Petzold S; Fille M; Rodloff AC Infection; 2005 Oct; 33(5-6):368-72. PubMed ID: 16258869 [TBL] [Abstract][Full Text] [Related]
25. Recent trends in diagnosis and treatment of Clostridium difficile in a tertiary care facility. Butterworth SA; Koppert E; Clarke A; Wiggs B; MacFarlane JK Am J Surg; 1998 May; 175(5):403-7. PubMed ID: 9600288 [TBL] [Abstract][Full Text] [Related]
26. New PCR ribotypes of Clostridium difficile detected in children in Brazil: prevalent types of Clostridium difficile in Brazil. Alcides AP; Brazier JS; Pinto LJ; Balassiano IT; Boente RF; de Paula GR; Ferreira EO; Avelar KE; Miranda KR; Ferreira MC; Domingues RM Antonie Van Leeuwenhoek; 2007 Jul; 92(1):53-9. PubMed ID: 17252315 [TBL] [Abstract][Full Text] [Related]
27. [In vitro activity of beta-lactams, clindamycin and metronidazole on Clostridium difficile]. Sedallian A; Debrueres J; Roudon T; Deronzier M Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):682-4. PubMed ID: 3054747 [TBL] [Abstract][Full Text] [Related]
28. Contributions to the taxonomy and biology of Clostridium difficile. Bittner J; Macovei A; Lemeni D; Arboreanu D; Potorac E Roum Arch Microbiol Immunol; 1992; 51(4):253-62. PubMed ID: 1304829 [TBL] [Abstract][Full Text] [Related]
29. Comparison of the E test and agar dilution method for antimicrobial suceptibility testing of Helicobacter pylori. Glupczynski Y; Broutet N; Cantagrel A; Andersen LP; Alarcon T; López-Brea M; Mégraud F Eur J Clin Microbiol Infect Dis; 2002 Jul; 21(7):549-52. PubMed ID: 12172749 [TBL] [Abstract][Full Text] [Related]
30. Pharmacodynamic studies of vancomycin, metronidazole and fusidic acid against Clostridium difficile. Odenholt I; Walder M; Wullt M Chemotherapy; 2007; 53(4):267-74. PubMed ID: 17595541 [TBL] [Abstract][Full Text] [Related]
31. Comparison of the E test to the reference agar dilution method for antibiotic susceptibility testing of Clostridium difficile. Poilane I; Cruaud P; Torlotin JC; Collignon A Clin Microbiol Infect; 2000 Mar; 6(3):155-6. PubMed ID: 11168094 [No Abstract] [Full Text] [Related]
32. Changes in sensitivity patterns to selected antibiotics in Clostridium difficile in geriatric in-patients over an 18-month period. Drummond LJ; McCoubrey J; Smith DGE; Starr JM; Poxton IR J Med Microbiol; 2003 Mar; 52(Pt 3):259-263. PubMed ID: 12621092 [TBL] [Abstract][Full Text] [Related]
33. Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Barbut F; Mastrantonio P; Delmée M; Brazier J; Kuijper E; Poxton I; Clin Microbiol Infect; 2007 Nov; 13(11):1048-57. PubMed ID: 17850341 [TBL] [Abstract][Full Text] [Related]
34. New approach to the management of Clostridium difficile infection: colonisation with non-toxigenic C. difficile during daily ampicillin or ceftriaxone administration. Merrigan MM; Sambol SP; Johnson S; Gerding DN Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S46-50. PubMed ID: 19303570 [TBL] [Abstract][Full Text] [Related]
35. Past, present, and future therapies for Clostridium difficile-associated disease. Surowiec D; Kuyumjian AG; Wynd MA; Cicogna CE Ann Pharmacother; 2006 Dec; 40(12):2155-63. PubMed ID: 17148650 [TBL] [Abstract][Full Text] [Related]
36. Comparison of Clostridium difficile minimum inhibitory concentrations obtained using agar dilution vs broth microdilution methods. Hastey CJ; Dale SE; Nary J; Citron D; Law JH; Roe-Carpenter DE; Chesnel L Anaerobe; 2017 Apr; 44():73-77. PubMed ID: 28188880 [TBL] [Abstract][Full Text] [Related]
37. Antimicrobial susceptibility of Clostridium difficile strains isolated from hospitalised patients with acute diarrhoea. Niyogi SK J Diarrhoeal Dis Res; 1992 Sep; 10(3):156-8. PubMed ID: 1430970 [TBL] [Abstract][Full Text] [Related]
38. In vitro activity of OPT-80 against Clostridium difficile. Ackermann G; Löffler B; Adler D; Rodloff AC Antimicrob Agents Chemother; 2004 Jun; 48(6):2280-2. PubMed ID: 15155234 [TBL] [Abstract][Full Text] [Related]
39. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin. Al-Nassir WN; Sethi AK; Nerandzic MM; Bobulsky GS; Jump RL; Donskey CJ Clin Infect Dis; 2008 Jul; 47(1):56-62. PubMed ID: 18491964 [TBL] [Abstract][Full Text] [Related]